Azilsartan Medoxomil Potassium/Chlorthalidone

阿齐沙坦酯钾盐/氯噻酮

Report date: 2023/04/23 14:54:09

Base Information

Drug NameAzilsartan Medoxomil Potassium/Chlorthalidone
Drug Alias Name氯噻酮/阿齐沙坦酯钾Azilsartan Medoxomil Potassium and Chlorthalidone阿齐沙坦酯钾/氯噻酮Azilsartan Medoxomil and Chlorthalidone氯噻酮/阿齐沙坦酯钾盐 +[13] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin II Receptor Type 1 antagonists
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2011/12/20
Country/TerritoryCanadaUnited StatesPoland +[11] 
CombinationsYes Azilsartan Medoxomil PotassiumChlorthalidone
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesArbor Pharmaceuticals Llc
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsHypertension
Inactive IndicationsEssential Hypertension

Other Information

ATC CodeC09DA09
Related LinksKEGG